Status of U.S. Biosimilar Approvals and Pending Applications*

Published date29 June 2018
Law FirmMcDonnell Boehnen Hulbert & Berghoff LLP
AuthorKevin E. Noonan
Subject MatterFDA,Biosimilars,Pharmaceutical Patents,BPCIA

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT